OP Bancorp
For the period ended Jun 30, 2026. Filed Aug 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 7, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
13 — Earnings Per Share
Note 13 —Earnings Per Share
The following table presents the calculation of the basic and diluted EPS for the three and six months ended June 30, 2026 and 2025. For more information on the calculation of EPS, see Note 1. Significant Accounting Policies to the Consolidated Financial Statements in the 2025 Annual Report on Form 10-K:
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| ($ in thousands, except share and per share data) | 2026 | 2025 | 2026 | 2025 |
| Basic | ||||
| Net income | $7,978 | $6,333 | $15,212 | $11,893 |
| Distributed and undistributed earnings allocated to participating securities | — | (53) | — | (127) |
| Net income allocated to common shares | $7,978 | $6,280 | $15,212 | $11,766 |
| Weighted-average number of common shares outstanding | 14,903,398 | 14,859,718 | 14,897,198 | 14,858,483 |
| Basic EPS | $0.54 | $0.42 | $1.02 | $0.79 |
| Diluted | ||||
| Net income allocated to common shares | $7,978 | $6,280 | $15,212 | $11,766 |
| Weighted-average number of common shares outstanding | 14,903,398 | 14,859,718 | 14,897,198 | 14,858,483 |
| Add: Dilutive impact of unvested restricted stock awards (1) | 38,732 | — | 39,324 | — |
| Average shares and dilutive potential common shares | 14,942,130 | 14,859,718 | 14,936,522 | 14,858,483 |
| Diluted earnings per common share | $0.53 | $0.42 | $1.02 | $0.79 |
(1)Approximately five thousand andeleven thousand weighted-average shares of anti-dilutive restricted stock awards were excluded from the diluted EPS computation for the three and six months ended June 30, 2026, respectively. No shares of common stock were antidilutive for the three and six months ended June 30, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.